Caffeine acts through neuronal adenosine A2A receptors to prevent mood and memory dysfunction triggered by chronic stress.
about
Depression as a Glial-Based Synaptic DysfunctionEarly synaptic deficits in the APP/PS1 mouse model of Alzheimer's disease involve neuronal adenosine A2A receptors.Signaling pathways underlying the antidepressant-like effect of inosine in miceCoffee provides a natural multitarget pharmacopeia against the hallmarks of cancer.Caffeine enhances the antidepressant-like activity of common antidepressant drugs in the forced swim test in miceIncreased Nanoparticle Delivery to Brain Tumors by Autocatalytic Priming for Improved Treatment and Imaging.The Role of Adenosine Signaling in Headache: A Review.Modulation of excitatory neurotransmission by neuronal/glial signalling molecules: interplay between purinergic and glutamatergic systems.Potential Therapeutic Applications of Adenosine A2A Receptor Ligands and Opportunities for A2A Receptor Imaging.How does adenosine control neuronal dysfunction and neurodegeneration?Having a Coffee Break: The Impact of Caffeine Consumption on Microglia-Mediated Inflammation in Neurodegenerative Diseases.Pathological overproduction: the bad side of adenosine.The neuroprotective effects of caffeine in neurodegenerative diseases.Date Palm Tree (Phoenix dactylifera L.): Natural Products and Therapeutic Options.Novel aspects of extracellular adenosine dynamics revealed by adenosine sensor cells.Adenosine A2A receptor inactivation alleviates early-onset cognitive dysfunction after traumatic brain injury involving an inhibition of tau hyperphosphorylationPurinergic Signalling: Therapeutic Developments.Adenosine A2A Receptors in the Amygdala Control Synaptic Plasticity and Contextual Fear Memory.Adenosine A2A receptor regulation of microglia morphological remodeling-gender bias in physiology and in a model of chronic anxiety.Treatment with A2A receptor antagonist KW6002 and caffeine intake regulate microglia reactivity and protect retina against transient ischemic damage.Istradefylline reduces memory deficits in aging mice with amyloid pathology.Purinergic system in psychiatric diseases.Low dose of caffeine enhances the efficacy of antidepressants in major depressive disorder and the underlying neural substrates.Caffeine Controls Glutamatergic Synaptic Transmission and Pyramidal Neuron Excitability in Human Neocortex.Caffeine Reverts Memory But Not Mood Impairment in a Depression-Prone Mouse Strain with Up-Regulated Adenosine A2A Receptor in Hippocampal Glutamate Synapses.Acyl ghrelin improves cognition, synaptic plasticity deficits and neuroinflammation following amyloid β (Aβ1-40) administration in mice.Impact of Coffee and Cacao Purine Metabolites on Neuroplasticity and Neurodegenerative Disease.Targeting astrocytes in bipolar disorder.Adenosine A2A Receptor Signaling in the Immunopathogenesis of Experimental Autoimmune Encephalomyelitis.Adenosine A2A Receptor Blockade Modulates Glucocorticoid-Induced Morphological Alterations in Axons, But Not in Dendrites, of Hippocampal Neurons.Caffeine and Modafinil Ameliorate the Neuroinflammation and Anxious Behavior in Rats during Sleep Deprivation by Inhibiting the Microglia Activation.Adenosine A2A Receptors Control Glutamatergic Synaptic Plasticity in Fast Spiking Interneurons of the Prefrontal Cortex.Behavioral changes induced through adenosine A2A receptor ligands in a rat depression model induced by olfactory bulbectomy.Periodical reactivation under the effect of caffeine attenuates fear memory expression in rats.Pharmacological Blockade of Adenosine A2A but Not A1 Receptors Enhances Goal-Directed Valuation in Satiety-Based Instrumental Behavior.Caffeine and Selective Adenosine Receptor Antagonists as New Therapeutic Tools for the Motivational Symptoms of Depression.Palmitoylation as a Functional Regulator of Neurotransmitter Receptors.Streptozotocin-induced diabetes mellitus affects the NMDA receptors: Role of caffeine administration in enhancing learning, memory and locomotor deficits.Effect of Ketamine on LTP and NMDAR EPSC in Hippocampus of the Chronic Social Defeat Stress Mice Model of DepressionBeneficial Effect of a Selective Adenosine A Receptor Antagonist in the APPswe/PS1dE9 Mouse Model of Alzheimer's Disease
P2860
Q26772830-C7C91787-E999-4CED-9D4E-877465E20A31Q27343149-2CCA38D3-7B30-4D4D-B4BA-72A2CC913872Q33689441-2B872DE1-3387-4B7D-B004-077B1683195FQ36289486-1E598468-8024-4B90-A55D-1DBE6D520A60Q36471008-0F093DF6-41D7-484B-9209-C29E62572A82Q37600688-982F87CD-6934-485C-B80B-59FD46106E2AQ37721517-95BAA4AE-028F-4A5B-9EEC-565ECE60FC35Q38358456-5D5EFCA9-B94D-466C-9261-D141443F0742Q38765118-271D3345-FFC0-4B50-A74F-E248B4F4E77FQ38882782-6FAE0D32-ACD4-4C30-B4CC-9CFCCDC66F81Q39157059-A3E95B37-0C48-43E7-9FC3-0D7F325D2B16Q39157893-EC6CC2AF-7A9D-4A99-A9D3-84DB1C34B7D7Q39186884-ED362DDA-208F-4C22-B226-759497B7D645Q39355455-5A1E15EB-99F1-4B54-8C68-200A7D0001CFQ41043672-26C58CDD-44FF-40B3-92D3-13F658EF796DQ41173271-528D68FF-5E53-48FB-ABF3-D882D5DA9266Q42367885-24BE2B95-F4EB-45A3-89E6-AB67BDA738D5Q42701014-FBE2E622-E1F5-4DC3-B989-E0D7E96157E7Q47386152-9F9CAEC0-1D2B-4FD5-AC58-FE3D19FBE3E2Q47387315-39066CAA-6B9E-4327-A927-D7F79E05B138Q47443548-3FD635CB-7821-4CF7-90BA-ED14E5B81732Q47758170-AA9AC116-FEAF-4301-962E-2A7C1FB952E4Q47777997-392C4977-0EDE-4061-81C9-C5FF8185FB6EQ47849247-ABA230B9-64F9-4C4E-BA9C-85B5A9D45264Q48064385-98C8900B-5B7F-4BD8-9CC9-49AA11EDEF46Q48316322-3E27CB86-6D5D-4453-B432-EFA1A5015027Q50125651-3BAE548F-620D-4AEE-961F-C77A733B26A9Q52143963-FCC5665B-4DAA-4CAD-A3E2-CD43FF427450Q52348482-95F0F7EE-28DC-47CD-A4C9-452E24680753Q52608764-B895C28C-969E-41E9-A9F5-3AD532FF3097Q52620604-EDE3BF0F-F89A-4EE9-8903-2D4A52C82772Q53418752-2DDEF7B9-E7FE-4512-8CCA-D05CB1323441Q53821043-25E46FC1-5F38-40FC-A80F-280511CFDEDBQ55030395-CE4C372F-065E-453D-BC43-E7727D807BA2Q55111952-D2D43BFE-D149-4592-ADBA-8688D6410494Q55132660-2F99AD65-78B1-4E0A-8F60-B50D1FBEDD3DQ55256658-42FFD0BD-6A63-49CA-891F-6E17E72E1639Q55316117-29A0C146-9721-492C-ABCC-C2A22724DB36Q57816585-BF5BFB5E-B6C6-41AE-BD08-6B5DA2706281Q57896338-C612B621-6228-49F1-8865-CB807665EB0A
P2860
Caffeine acts through neuronal adenosine A2A receptors to prevent mood and memory dysfunction triggered by chronic stress.
description
2015 nî lūn-bûn
@nan
2015 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Caffeine acts through neuronal ...... on triggered by chronic stress
@nl
Caffeine acts through neuronal ...... n triggered by chronic stress.
@ast
Caffeine acts through neuronal ...... n triggered by chronic stress.
@en
type
label
Caffeine acts through neuronal ...... on triggered by chronic stress
@nl
Caffeine acts through neuronal ...... n triggered by chronic stress.
@ast
Caffeine acts through neuronal ...... n triggered by chronic stress.
@en
prefLabel
Caffeine acts through neuronal ...... on triggered by chronic stress
@nl
Caffeine acts through neuronal ...... n triggered by chronic stress.
@ast
Caffeine acts through neuronal ...... n triggered by chronic stress.
@en
P2093
P2860
P50
P3181
P356
P1476
Caffeine acts through neuronal ...... n triggered by chronic stress.
@en
P2093
Ana Paula Ardais
Jiang Fan Chen
Lisiane O Porciúncula
P2860
P304
P3181
P356
10.1073/PNAS.1423088112
P407
P50
P577
2015-06-08T00:00:00Z